Labcorp Holdings logo

Labcorp Holdings (LH) Q1 2026 Earnings

LH·Reported April 30, 2026·Before market open

Labcorp Holdings reported Q1 2026 revenue of $3.5B (+5.8% YoY), beat analyst consensus of $3.5B by $28.8M. Diluted EPS came in at $4.25 (+10.7% YoY), beat the $4.09 consensus by $0.16. Labcorp Holdings reports across 2 business segments, led by Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS).

Revenue
$3.5Bbeat by $28.8M
Consensus: $3.5B
Diluted EPS
$4.25beat by $0.16
Consensus: $4.09
SEC

SEC Filings

Earnings release8-K · 0000920148-26-000135
Quarterly report10-Q · 0000920148-26-000139

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Revenue

View metric

Q1 2026 Earnings FAQ

Common questions about Labcorp Holdings's Q1 2026 earnings report.

Labcorp Holdings (LH) reported Q1 2026 earnings on April 30, 2026 before market open.

Labcorp Holdings reported revenue of $3.5B and diluted EPS of $4.25 for Q1 2026.

Revenue beat the consensus estimate of $3.5B by $28.8M. EPS beat the consensus estimate of $4.09 by $0.16.

Compared to the same quarter a year prior, revenue grew 5.8% from $3.3B a year earlier and diluted EPS grew 10.7% from $3.84.

You can read the 8-K earnings release (0000920148-26-000135) and the 10-Q periodic report (0000920148-26-000139) directly on SEC EDGAR. The filing index links above go to sec.gov.